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hepatocyteWe recently reported that hepatocyte mitochondrial aquaporin-8 (mtAQP8) channels facilitate the
uptake of ammonia and its metabolism into urea. Here we studied the effect of bacterial lipopoly-
saccharides (LPS) on ammonia-derived ureagenesis. In LPS-treated rats, hepatic mtAQP8 protein
expression and diffusional ammonia permeability (measured utilizing ammonia analogues) of liver
inner mitochondrial membranes were downregulated. NMR studies using 15 N-labeled ammonia
indicated that basal and glucagon-induced ureagenesis from ammonia were signiﬁcantly reduced
in hepatocytes from LPS-treated rats. Our data suggest that hepatocyte mtAQP8-mediated ammonia
removal via ureagenesis is impaired by LPS, a mechanism potentially relevant to the molecular
pathogenesis of defective hepatic ammonia detoxiﬁcation in sepsis.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Liver metabolizes ammonia in periportal hepatocytes by urea-
genesis and in perivenous hepatocytes by glutamine synthesis
[1]. This is critical for preventing hyperammonemia and hepatic
encephalopathy [2,3]. Sepsis can precipitate hyperammonemia
and its deleterious effects in patients with acute liver failure and
cirrhosis [4,5]. Liver dysfunction and increased plasma ammonia
is also observed in rodent models of sepsis [6,7]. The molecular
mechanisms involved in the defective hepatic ammonia detoxiﬁca-
tion have not been yet fully elucidated. It has been demonstrated
that bacterial lipopolysaccharides (LPS) induce inhibition of
hepatic ammonia removal via glutamine synthesis [8]; neverthe-
less, an impairment of ammonia removal via urea synthesis mayalso be involved. Aquaporin-8 (AQP8) is a member of a family of
homologous membrane channel proteins demonstrated to facili-
tate the diffusional transport of ammonia [9–12]. In hepatocytes,
a non-glycosylated 28 kDa form of AQP8 is present at the inner
mitochondrial membranes (IMM) [13,14]. The expression of mito-
chondrial AQP8 (mtAQP8) seems to be greater in the periportal
area of the hepatic lobule [13,14]. There is experimental evidence
suggesting that mtAQP8 facilitates the ammonia transport across
the IMM [15–17]. We recently reported that hepatocyte mtAQP8
is involved in the mitochondrial uptake of ammonia and its metab-
olism into urea [17]. Hence, in this study, we investigated whether
mtAQP8 is involved in the molecular pathogenesis of the LPS-in-
duced defective hepatic ammonia detoxiﬁcation.
2. Materials and methods
2.1. LPS treatment
Adult male Wistar rats were maintained on a standard diet and
water ad libitum, and housed in a temperature- and humidity-con-
trolled environment under a constant 12:12-h light–dark cycle,
according to the Guide for the Care and Use of Laboratory Animals
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Animal Welfare Committee. The experimental model was induced
by injecting rats via the femoral vein with Salmonella typhimurium
LPS (4 mg/kg body wt) (Sigma, St. Louis, MO) dissolved in sterile
0.9% NaCl under ether anesthesia [18]. Control rats were injected
with saline only. After 16 h, animals were euthanized, and livers
were harvested for evaluation. Ammonia concentration in blood
was measured using a commercial kit (Randox Laboratories Ltd.,
Crumlim, UK), according to the manufacturer’s instructions. Liver
urea content was determined in liver homogenates by the urease
method [19].
2.2. Isolation and culture of hepatocytes
Hepatocytes were isolated from control and LPS-treated livers
of male Wistar rats by collagenase perfusion and mechanical
disruption [20]. Cell viability (assessed by Trypan blue exclusion)
was greater than 90%. Hepatocytes were plated onto collagen-
coated glass plates at 1.9  104 cells/cm2, in DMEM medium (high
glucose, with 1 mM sodium pyruvate, and without L-glutamine)
supplemented with 10% FBS (PAA Laboratories GmbH, Linz, Aus-
tria), penicillin (100 units/ml), and streptomycin (100 lg/ml)
(Invitrogen, San Diego, CA). Cells were incubated at 37 C in a
humidiﬁed atmosphere with 5% CO2 for 3 h, allowing cell attach-
ment to plates. After that time, medium was changed, and hepato-
cytes were incubated according to the protocols described below.
At the end of the experiments, cells were washed and sonicated
in 0.3 M sucrose (Merck Chemicals, Darmstadt, Germany).
2.3. Hepatocyte urea production
Hepatocytes were incubated in the presence of 1 mM ammo-
nium chloride or 4 mM L-glutamine at 37 C for 4 h in the absence
or presence of 1 lM glucagon. All the experiments were done in
the presence of L-ornithine (4 mM) (Sigma, St. Louis, MO, USA).
Furthermore, as urea has two nitrogens, one coming from ammo-
nia and one from aspartate, it is worth mentioning that culture
media contained pyruvate as a source of aspartate [21]. At the
end of the experiments, the culture medium was aspirated and
centrifuged at 500g for 5 min to obtain a cell-free supernatant for
determination of urea by the urease method [19].
2.4. Assessment of 15N-labeled urea by nuclear magnetic resonance
spectroscopy
Control and LPS hepatocytes were incubated with 1 mM 15N-la-
beled ammonium chloride (99% enriched in 15N, Cambridge Iso-
tope Laboratories, Andover, MA) at 37 C for 4 h in the absence or
presence of 1 lM glucagon. The culture medium was then aspi-
rated, centrifuged at 500g for 5 min at 4 C, and lyophilized. The
lyophilizate was resuspended in 0.5 ml of dimethyl sulfoxide-d6
(99.9 atom% D) (Cambridge Isotope Laboratories) containing
0.02 ml of formamide [natural abundance (0.365%) in 15N] (Prome-
ga), that was used as internal standard. 15N-labeled urea synthesis
was determined by nuclear magnetic resonance spectroscopy, as
previously described [17].
2.5. Preparation of mitochondrial and submitochondrial fractions
Liver samples were homogenized by 15 up-down strokes with a
loose ﬁtting Dounce homogenizer in four volumes of 0.3 M sucrose,
containing the protease inhibitors 0.1 mM Phenyl-methylsulfonyl
ﬂuoride and 0.1 mM Leupeptin (Sigma). Sonicated hepatocyte cells
(or liver homogenates) were subjected to low-speed centrifugation
to obtain post-nuclear supernatants, which were then centrifuged
at 6000g for 10 min at 4 C, yielding the mitochondrial fraction.Mitochondria were washed twice before being resuspended in
the appropriate buffers or were used to obtain IMM as described
by Ragan et al. [22]. Firstly, mitoplasts were prepared by using
the detergent approach. Brieﬂy, digitonin (Sigma) was added to a
suspension of mitochondria (100 mg of protein/ml) to a ﬁnal con-
centration of 0.6% w/v in 0.3 M sucrose and incubated for 15 min
on ice under gentle stirring. After dilution with 3 volumes of
0.3 M sucrose, the suspension was centrifuged at 15000g for
10 min at 4 C. The resulting pellet (mitoplasts) was resuspended
in isolation medium at a protein concentration of 15 mg/ml before
being subjected to ﬁve cycles of sonication (5 s at the maximum
energy setting each with 30-s cooling periods). After sonication,
mitoplasts were diluted with an equal volume of isolation medium
and centrifuged at 15000g for 10 min at 4 C. The resulting pellet
was resuspended in 10 volumes of 0.3 M sucrose and centrifuged
again at 100000g; this process was repeated twice. The ﬁnal pellet,
i.e., the IMM vesicles, was resuspended in 0.3 M sucrose with
protease inhibitors. Protein content was determined according to
Lowry et al. [23].
2.6. Stopped ﬂow light scattering measurement of formamide
permeability
For measurement of formamide permeability, mitochondria
were subjected to a 150 mM inwardly directed gradient of form-
amide as previously reported [15]. The time course of mitochon-
drial volume change was followed from changes in intensity of
scattered light intensity at 20 C at the wavelength of 450 nm by
using a SX.18MVR stopped-ﬂow spectrometer (Applied Photophys-
ics, Surrey, UK), which has a 1.3-ms dead time and 99% mixing efﬁ-
ciency in <1 ms. There was a biphasic response, a rapid shrinkage
of mitochondria due to the exit of water until the osmotic equilib-
rium was reached, followed by a much slower swelling of
mitochondria corresponding to the inﬂux of formamide accompa-
nied by water. Mitochondrial swelling data (i.e., formamide trans-
port) were ﬁtted to a decreasing single exponential function with
rate constant, Ki (s1). The Ki of swelling was used as an indirect
biophysical parameter for assessment of formamide mitochondrial
permeability. The corresponding solute permeability coefﬁcients
were not calculated because of biophysical (i.e., presence of two
membranes in series) and morphological (i.e., rod-shaped struc-
tures of heterogeneous size) constraints of mitochondria [15].
2.7. Uptake of [14C]methylamine in inner mitochondrial membrane
vesicles
IMM vesicles were prepared from control and LPS-treated rats.
The transport of ammonia in these vesicles was measured using
the ammonia analog [14C]methylamine, by the rapid ﬁltration
technique as previously described [17]. Methylamine is an analog
structurally similar to ammonia but of larger size. Thus IMM
ammonia permeability may be somewhat underestimated.
2.8. Immunoblotting
Solubilized mitochondrial membrane fractions were heated
10 min at 90 C in sample buffer (20 mM Tris, pH 8.5, 1% SDS,
400 lM DTT, 10% glycerol), subjected to 12% SDS-polyacrylamide
gel electrophoresis and transferred to polyvinyl diﬂuoride mem-
branes (NEN Life Science Products, Boston, MA). After blocking
and washing, blots were incubated overnight at 4 C with rabbit
afﬁnity puriﬁed antibody directed against an N-terminal peptide
of rat AQP8 [14,17] or rabbit antibodies against Carbamyl phos-
phate synthetase 1 (CPS1) and Ornithine transcarbamylase (OTC)
(Sigma). As loading control, membranes were also incubated with
rabbit antibodies against Prohibitin (Abcam, Cambridge, UK) all at
1688 L.R. Soria et al. / FEBS Letters 588 (2014) 1686–1691a ﬁnal concentration of 1 lg/ml. The blots were washed and incu-
bated with the horseradish peroxidase-conjugated corresponding
secondary antibodies. Protein bands were detected by enhanced
chemiluminescence detection system (ECL, Thermo Scientiﬁc, IL,
USA). Autoradiographs were obtained by exposing the membranes
to Kodak XAR ﬁlms (Eastman Kodak, Rochester, NY). Densitometric
analysis of the developed bands was performed using Image J Soft-
ware [24].
2.9. Statistical analysis
Data are expressed as means ± S.E. Signiﬁcance was determined
using Student’s t-test or the 1-way ANOVA, Tukey test. P < 0.05 was
considered as statistically signiﬁcant.3. Results
3.1. Hepatic mtAQP8 expression and mitochondrial ammonia
transport in LPS-treated rats
LPS administration to rodents is an experimental model of
sepsis-induced liver dysfunction associated with hyperammone-
mia [6,7]. Thus, plasma ammonia concentration was found to be
increased by about 44% in LPS-treated vs. control rats (i.e., 156 ±
13 vs. 108 ± 5 lM, n = 5, P < 0.05). Consistently, LPS caused a reduc-
tion of urea synthesis as indicated by a 40% decrease in liver ureaA
Fig. 2. Hepatic mitochondrial ammonia transport: stopped ﬂow spectrophotometry. Rat
livers were collected and processed. (A) Representative results of stopped ﬂow light scatt
inwardly directed concentration gradient of formamide. Traces reﬂect the slower decreas
water inﬂux (for details see Section 2.6). (B) Calculated rate constants (Ki, s1) of mitochon








Fig. 1. Liver expression of mtAQP8 in LPS-treated rats. Rats were injected with LPS (4
processed (see Section 2.5). (A) Representative immunoblottings for mtAQP8 and the mito
The protein expression of mtAQP8 was decreased in LPS-treated rats. Each lane was load
equal protein loading. (B) Densitometric analysis of mtAQP8, CPS1, and OTC protein expcontent compared with control rats (i.e., 1.0 ± 0.1 vs. 1.7 ± 0.1 mg
urea/g liver, n = 5, P < 0.05).
Immunoblotting of puriﬁed liver mitochondria was performed
to examine the effect of LPS on the hepatocyte mtAQP8 protein
expression. As seen on Fig. 1A and B, mtAQP8 protein levels were
signiﬁcantly reduced by 80% (P < 0.05). However, the expression
of mitochondrial urea cycle enzymes, CPS1 and OTC, remained
unaltered.
We then investigated hepatic mitochondrial ammonia transport
by two different approaches previously described by us [15,17]: (1)
stopped ﬂow light scattering in isolated mitochondria using
formamide as ammonia analog (Fig. 2), and (2) rapid ﬁltration
technique in IMM vesicles using the ammonia analog [14C]methyl-
amine (Fig. 3).
Stopped ﬂow data (i.e., formamide transport) ﬁtted well to a
decreasing single exponential curve indicating a functionally
homogeneous population of mitochondria. Formamide diffusion
was slower in mitochondria from LPS-treated rats than in control
mitochondria (Fig. 2A). The calculated single exponential rate con-
stants of mitochondrial formamide transport depicted in Fig. 2B
were 32% lower in LPS-treated rats (3.2 ± 0.1 s1) than in controls
(4.7 ± 0.2 s1).
In agreement, Fig. 3A and B show that the uptake of
[14C]methylamine in liver IMM vesicles from LPS-treated rats
was reduced by about 40% (P < 0.05). A signiﬁcant reduction in
mtAQP8 protein expression after LPS treatment is observed in ali-
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Fig. 3. Hepatic mitochondrial ammonia transport: rapid ﬁltration technique. Rats were injected with LPS (4 mg/kg body wt) or saline alone (Control: C). After 16 h, livers
were collected and processed. (A) Flow chart of the transport analysis carried out with IMM vesicles using the ammonia analog [14C]methylamine ([14C]MA) and the rapid
ﬁltration technique (for details see Section 2.7). (B) [14C]methylamine uptake in liver IMM vesicles prepared from control and LPS-treated rats. The diffusional permeability of
[14C]methylamine decreased by about 40% (P < 0.05) in LPS-treated rats. (C) Immunoblotting for mtAQP8 protein in the IMM vesicles used for the transport studies with
corresponding densitometric analysis of mtAQP8 protein expression. In agreement with data in Fig. 1, mtAQP8 protein expression was signiﬁcantly reduced at 16-h of LPS
treatment. Data are means ± S.E. of three independent experiments. ⁄P < 0.05. Prohibitin (Pro), an IMM marker, is shown as a control for equal protein loading. Each lane was































Fig. 4. Basal and glucagon-stimulated ureagenesis from ammonia and glutamine in
hepatocytes from LPS-treated rats. Rats were injected with LPS (4 mg/kg body wt)
or saline alone (Control: C). After 16 h, hepatocytes were isolated from control and
LPS-treated rat livers as described in Section 2.2. Control and LPS hepatocytes were
incubated in the presence of 1 mM ammonium chloride or 4 mM glutamine at 37 C
for 4 h in the absence or presence of 1 lM glucagon. Urea was determined
enzymatically in the culture media. Data are means ± S.E. of three independent
experiments. ⁄P < 0.05 from control cells. #P < 0.05 from basal values.
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downregulation of hepatocyte mtAQP8 protein along with a de-
crease in mitochondrial ammonia diffusional permeability.
3.2. Ureagenesis in primary cultured hepatocytes from LPS-treated rats
Hepatocytes isolated from LPS-treated and control rats were
cultured in media containing ammonia as substrate for urea syn-
thesis. The mtAQP8 protein expression, assessed by immunoblot-
ting, was conﬁrmed to be downregulated in primary hepatocytes
from LPS-treated rats (50%; P < 0.05; n = 3) (data not shown).
We found that in hepatocytes from LPS-treated rats, basal ure-
agenesis from ammonia signiﬁcantly decreased by about 30% while
that from glutamine was actually increased (Fig. 4).
As glucagon is a known inducer of ureagenesis [4], its action on
urea production was directly explored in LPS hepatocytes.Glucagon-stimulated ureagenesis from ammonia, but not that
from glutamine, was signiﬁcantly inhibited in LPS hepatocytes
(Fig. 4).
To conﬁrm the LPS-induced defective ureagenesis from ammo-
nia, we made use of 15N-labeled ammonium chloride and mea-
sured 15N-labeled urea synthesis by NMR. Fig. 5A shows
representative data from NMR studies of ureagenesis under the ba-
sal and glucagon-stimulated condition. Consistent with the above
results of ureagenesis analysis, both basal and glucagon-stimulated
15N-labeled urea synthesis were signiﬁcantly decreased by around
30% in LPS hepatocytes (Fig. 5A and B).
Taken together, these results suggest that the downregulation
of hepatocyte mtAQP8 expression leads to defective ureagenesis
from ammonia in LPS-treated rats.
4. Discussion
We recently reported that hepatocyte mtAQP8 facilitates the
mitochondrial uptake of ammonia and its metabolism into urea
[15,17]. The major ﬁnding of the present study relates to the effect
of LPS on the functional expression of hepatocyte mtAQP8. We pro-
vide experimental evidence that (i) hepatocyte mtAQP8 protein
expression is downregulated in LPS-treated rats along with a
decrease in mitochondrial ammonia diffusional permeability,
measured utilizing ammonia analogues and (ii) LPS impairs hepa-
tocyte ureagenesis from ammonia, but not from glutamine, under
both basal and glucagon-stimulated conditions. A role for mtAQP8
in the molecular pathogenesis of defective hepatic ammonia
detoxiﬁcation in sepsis is suggested.
To prevent hyperammonemia and its deleterious effects, liver
detoxiﬁes ammonia by ureagenesis in periportal hepatocytes and
by glutamine synthesis in perivenous hepatocytes. Hyperammone-
mia is observed in experimental rodent models of sepsis, such as
cecal ligation and puncture [6] or LPS administration [7] suggesting
defective hepatic ammonia detoxiﬁcation. In fact, LPS has been
demonstrated to inhibit hepatic glutamine synthesis through the
inactivation of the glutamine synthetase [8]. Nevertheless, studies
in isolated perfused livers from septic [25] or LPS-treated [8] rats
showed a slightly or not affected ammonia metabolism via
ureagenesis.
Our LPS-treated rats showed increased plasma ammonia along
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Fig. 5. Basal and glucagon-stimulated 15N-labeled ureagenesis from 15N-labeled ammonia in hepatocytes from LPS-treated rats. Rats were injected with LPS (4 mg/kg body
wt) or saline alone (Control: C). After 16 h, hepatocytes were isolated from control and LPS-treated rat livers as described in Section 2.2. Control and LPS hepatocytes were
incubated with 15N-labeled ammonium chloride (1 mM) at 37 C for 4 h in the absence or presence of 1 lM glucagon. 15N-urea synthesis was measured by NMR as described
in Section 2.4. (A) Representative 15N-NMR spectra for urea under basal and glucagon stimulation. (B) Quantitation of total 15N-labeled urea normalized to the internal
standard, corresponding to three independent 15N-NMR spectra. 15N-labeled urea synthesis was signiﬁcantly reduced in hepatocytes isolated from LPS-treated rats under
basal as well as in glucagon-induced ureagenesis. Data are expressed as the percentage of control hepatocytes and represent the mean ± S.E. of three independent
experiments. ⁄P < 0.05 from control cells.
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agenesis from ammonia, either basal or glucagon-stimulated, was
signiﬁcantly dysregulated (see Figs. 4 and 5). In agreement with
studies in isolated perfused livers from septic animals [25], hepato-
cytes from the LPS-treated rats showed increased ureagenesis from
glutamine. Thus, hepatocyte ureagenesis in LPS-treated rats seems
to be functional but dependent on the speciﬁc source of precursors.
It is of note that ammonia has to diffuse into the mitochondrial
matrix, while glutamine is an intramitochondrial source of ammo-
nia. Glutamine, after being taken up into mitochondria, is metabo-
lized to ammonia and glutamate via glutaminase [26,27]. In
mitochondria, ammonia is a substrate for the synthesis of carbam-
oyl phosphate by CPS1, i.e., the ﬁrst step in the urea cycle necessary
for ammonia detoxiﬁcation. As previously reported [28] and con-
ﬁrmed in our study for CPS1 and OTC (Fig. 1), LPS does not alter
protein expression of urea cycle enzymes. The increased ureagen-
esis from glutamine is consistent with an LPS-induced hepatic
glutaminase activation [29].
There is evidence that ammonia diffusion across the IMM is
facilitated by mtAQP8 [15–17]. Moreover, mtAQP8 expression
seems to be important for hepatocyte ureagenesis from ammonia
[17]. We found that in LPS-treated rats, as recently reported in
septic rats [30], mtAQP8 protein expression is downregulated
(Fig. 1). Consequently, the ammonia permeability of IMM was
found to be reduced (Figs. 2 and 3). Thus, a constrained mtAQP8-
mediated ammonia diffusion to supply the urea cycle is expected.
AQP9, an AQP expressed at sinusoidal membranes, has been
found to be involved in hepatocyte urea release [31]. We previ-
ously showed that hepatic AQP9 expression was unchanged in rats
treated with LPS [18]. Accordingly, no accumulation of 15N-urea in
the cytosol of hepatocytes from LPS-treated rats was observed
(data not shown).
In hepatocytes, AQP8 is also expressed at canalicular mem-
branes [32,33] where it facilitates water transport during bile
secretion [33–35]. In rats subjected to cecal ligation and puncture,or to LPS treatment, canalicular AQP8 is down-regulated by post-
translational mechanisms, i.e., increased protein degradation
[18,36]. The LPS-induced cytokine tumor necrosis factor a medi-
ates the defective expression of canalicular AQP8 [18]. Further
studies are needed to determine whether these mechanisms are
implicated in the LPS-induced down-regulation of mtAQP8.5. Conclusions
Overall, our data suggest an LPS-induced impairment of the he-
patic mtAQP8-mediated ammonia metabolism to urea. This mech-
anism may be relevant to the molecular pathogenesis of defective
hepatic ammonia detoxiﬁcation in sepsis.
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